UNSPSC 51283928: Sulfaquinoxaline

This classification denotes a sulfonamide anti-infective agent with the molecular formula C14H12N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WNW8115TM9, chemically known as sulfanilamide, n(sup1)-2-quinoxalinyl- but generally known as sulfaquinoxaline, which bears US NIH Compound Identifier 5338. European Medicines Agency schedules Sulfaquinoxaline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10725MIG. The term SULFAQUINOXALINE is an International Non-Proprietary Name.

UNSPSC 51283928 Sulfaquinoxaline is a Commodity code that covers pharmaceutical active ingredients and compounds used in animal health and disease treatment, though recent state and local procurement activity under this code shows minimal volume. The code designation does not align closely with the actual purchases appearing in recent solicitations — the opportunities posted under or near this taxonomy involve finished pharmaceuticals (Doxycycline Hyclate, Ciprofloxacin Hydrochloride, and Naloxone) and drug-disposal systems rather than the raw sulfaquinoxaline compound itself. State and local health departments and county community health programs are the primary issuing bodies driving activity, using cooperative purchasing vehicles and traditional competitive bidding to source pharmaceutical supplies for public health initiatives, emergency response, and substance-abuse treatment programs.

Recent activity spans Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium in August 2026 (Solicitation 26482DPHPREPDB53392, IFB format, completed award) for Doxycycline Hyclate and Ciprofloxacin supplies over 12 months with two renewal options. Seminole County, Florida issued an IFB (IFB60459723LAS) in June 2026 seeking annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to its Community Health Building, awarded on a fixed-fee basis over an initial two-year term with one-year renewal option. Both procurements emphasize vendor compliance with drug-free workplace certification, E-Verify requirements, and applicable insurance coverage, with deliveries structured around public health facility locations and operational schedules.